ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Alzheimer's Caregiver Communication Study

This study is ongoing, but not recruiting participants.

Sponsored by: National Institute on Aging (NIA)
Information provided by: National Institute on Aging (NIA)
ClinicalTrials.gov Identifier: NCT00182988
  Purpose

The point of this research is to improve the communicative relationship between the caregiver and care receiver. It is input from the caregiver on these communicative behaviors that will inform the process of understanding how to reduce the caregiver burden that comes from this communicative relationship.


Condition
Alzheimer's Disease

Genetics Home Reference related topics:   Alzheimer disease  

MedlinePlus related topics:   Alzheimer's Caregivers   Alzheimer's Disease   Caregivers  

U.S. FDA Resources

Study Type:   Observational
Study Design:   Prospective
Official Title:   Alzheimer's Caregiver Ratings of Communication & Coping Behavior

Further study details as provided by National Institute on Aging (NIA):

Estimated Enrollment:   140
Study Start Date:   October 2004
Estimated Study Completion Date:   December 2007

Detailed Description:

This research study is developing a new checklist to measure communicative coping behaviors of persons with Alzheimer's Disease in the home environment. The Communicative Coping Behavior Checklist (CCBC) is an observation checklist to be completed by the caregiver or knowledgeable informant. The current version includes 23 behaviors to be rated for frequency and effectiveness. The behaviors that will be observed cover management of memory loss within three broad categories: humor, explanations, and general coping behaviors.

Two kinds of couples will participate in this study. One includes a person with Alzheimer's Disease and their caregiver. The second includes a cognitively intact participant and study partner, both over the age of 60, to serve as controls.

Study Visit 1 (3 hours long) During the first visit, the person with Alzheimer's Disease/control participant can expect to be asked questions about their memory, thinking and concentration, demographics, quality of life, and mood. The caregiver/study partner will be asked about their quality of life, mood, and daily activities.

At the end of the visit the caregiver/study partner will be given a copy of the CCBC and asked to take it home. S/he will be instructed to rate the person with Alzheimer's Disease/ control participant's communicative coping behavior over the course of the next two weeks. At the end of that time, a research assistant will call the caregiver/study partner and administer the CCBC over the telephone.

Study Visit 2 (3 hours long) The second visit will occur in the clinic approximately 12 months from the date of the first visit. As with the first study visit, again both the person with Alzheimer's Disease/control participant and the caregiver/study partner will answer questions about their memory, quality of life, mood, and daily activities. Once again, the caregiver/study partner will be given a copy of the CCBC and asked to take it home and complete.

Both visits will take about three hours for the caregiver/study partner and about two hours for the person with dementia or control subject.

  Eligibility
Ages Eligible for Study:   60 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Criteria

*Note* Currently enrolling participants for control group only

Inclusion Criteria:

  • Couples including spouse or family member who spend at least 2-3 hours per day together
  • Both must be cognitively intact

Exclusion Criteria:

  • Cognitive impairment
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00182988

Locations
United States, District of Columbia
Georgetown University Medical Center    
      Washington, District of Columbia, United States, 22057

Sponsors and Collaborators

Investigators
Principal Investigator:     Pamela Saunders, PhD     Georgetown University    
  More Information

Responsible Party:   Georgetown University ( Pamela A. Saunders, Ph.D. )
Study ID Numbers:   IA0082, 1RO3AG022627
First Received:   September 13, 2005
Last Updated:   December 12, 2007
ClinicalTrials.gov Identifier:   NCT00182988
Health Authority:   United States: Federal Government

Keywords provided by National Institute on Aging (NIA):
communication behavior  
coping  
functional ability  
quality of life  
caregiving  

Study placed in the following topic categories:
Delirium, Dementia, Amnestic, Cognitive Disorders
Alzheimer Disease
Quality of Life
Central Nervous System Diseases
Neurodegenerative Diseases
Brain Diseases
Dementia
Cognition Disorders
Delirium

Additional relevant MeSH terms:
Mental Disorders
Nervous System Diseases
Tauopathies

ClinicalTrials.gov processed this record on July 03, 2008




Links to all studies - primarily for crawlers